Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTRS Viatris Inc.

盘后交易 12-24 14:29:52 EST

12.40

-0.09

-0.72%

盘后12.30

-0.10-0.81%

14:20 EST

最高12.41	最低12.12	成交量403.45万
今开12.25	昨收12.49	日振幅2.32%
总市值148.01亿	流通市值147.18亿	总股本11.94亿
成交额4,974万	换手率0.34%	流通股本11.87亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTRS","market":"US","secType":"STK","nameCN":"Viatris Inc.","latestPrice":12.4,"timestamp":1735063199999,"preClose":12.49,"halted":0,"volume":4034533,"hourTrading":{"tag":"盘后","latestPrice":12.3,"preClose":12.4,"latestTime":"14:20 EST","volume":32847,"amount":407266.208442,"timestamp":1735068028486},"delay":0,"floatShares":1186953302,"shares":1193592902,"eps":-0.739178,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.09,"latestTime":"12-24 14:29:52 EST","open":12.25,"high":12.41,"low":12.12,"amount":49744311.216389,"amplitude":0.023219,"askPrice":12.46,"askSize":1,"bidPrice":12.3,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-0.739178,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735077600000},"adr":0,"listingDate":1605157200000,"adjPreClose":12.49,"dividendRate":0.03871,"preHourTrading":{"tag":"盘前","latestPrice":12.25,"preClose":12.49,"latestTime":"09:27 EST","volume":15269,"amount":188103.254279,"timestamp":1735050474749},"postHourTrading":{"tag":"盘后","latestPrice":12.3,"preClose":12.4,"latestTime":"14:20 EST","volume":32847,"amount":407266.208442,"timestamp":1735068028486},"volumeRatio":0.426394,"impliedVol":0.2882,"impliedVolPercentile":0.3333},"requestUrl":"/m/hq/s/VTRS","defaultTab":"news","newsList":[{"id":"2493792757","title":"更新版 1-美国 FDA 限制进口印度生产的部分 Viatris 产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2493792757","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493792757?lang=zh_cn&edition=full","pubTime":"2024-12-23 21:29","pubTimestamp":1734960555,"startTime":"0","endTime":"0","summary":"     路透12月23日 - Viatris   周一称，美国食品和药物管理局已限制其印度制药厂生产的11种产品的进口，因为该厂违反了联邦要求。美国食品和药物管理局在对该工厂进行检查后向该制药商发出了 警告信，并表示 在警告信解除之前，美国将不再接受这些产品。Viatris 表示， 该机构 基于短缺问题对四种产品 做出了有条件的例外 处理。Viatris 和 FDA 没有立即回应路透的置评请求 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"更新版 1-美国 FDA 限制进口印度生产的部分 Viatris 产品","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","LU2087621335.USD","BK4585","VTRS","BK4588","BK4583","BK4007"],"gpt_icon":0},{"id":"2493752476","title":"美国 FDA 就印度生产设施向 Viatris 发出警告信","url":"https://stock-news.laohu8.com/highlight/detail?id=2493752476","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493752476?lang=zh_cn&edition=full","pubTime":"2024-12-23 21:08","pubTimestamp":1734959330,"startTime":"0","endTime":"0","summary":"美国 FDA 就印度生产设施向 Viatris 发出警告信路透12月23日 - Viatris VTRS.O周一表示，在今年早些时候对其位于印度印多尔的口服成品药生产厂进行检查后，该公司收到了美国食品和药物管理局的警告信。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4S3NO0Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4007","BK4588","LU2087621335.USD","VTRS","LU1839511570.USD","BK4585"],"gpt_icon":0},{"id":"2485929061","title":"BUZZ--美国股票走势-CC 控股公司、世邦魏理仕、莱克西康制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2485929061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485929061?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:48","pubTimestamp":1732301316,"startTime":"0","endTime":"0","summary":"** Arm Holdings PLC   : BUZZ - 富国银行将其评级定为 \"增持\"。** Copart Inc   : BUZZ - 因飓风过后的销售而实现季度营收增长。** Tapestry Inc   : BUZZ - 在 20 亿美元的加速股票回购计划后涨至逾十年新高   ** Eyenovia Inc   : BUZZ - 因采取更多削减成本行动和推迟债务偿还而上涨   ** Reddit Inc   : BUZZ - 在腾讯披露股票销售后从创纪录水平回落。** Viking Therapeutics Inc   ： BUZZ--上涨；B.Riley给予 \"买入 \"评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLEX","BKE","NEM","THC","TPR","SLG","DOG","CC","HON",".IXIC",".DJI","VTRS","EOG",".SPX","LIPO","AXP","CTXR","APG","JTAI","NTAP","EYEN","QID","AMIX","DJX","CBG","CPRT","WTW","RUN","INTU","LXRX","CYH","CBRE","FFWM","HALO","PSQ","WAY","VKTX","QLD","ROST","HCA"],"gpt_icon":1},{"id":"2485298286","title":"BUZZ--美国股票走势-Jet.AI, SL Green, WTW","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298286","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298286?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:09","pubTimestamp":1732291794,"startTime":"0","endTime":"0","summary":".N美东时间10:30，道琼斯工业平均指数.DJI上涨0.38%，报44038.76点。标普500指数.SPX持平于0%，报5948.51点；纳斯达克综合指数.IXIC下跌0.34%，报18908.67点。标准普尔 500 指数.PG.INX涨幅前三名是： ** 超级微型计算机公司SMCI.O，上涨 10.6. ** 莫德纳 Inc MRNA.O，上涨 5.6 标准普尔 500 指数.PL.INX跌幅前三名： ** Intuit Inc INTU.O，下跌 4.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4S3MT187:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RUN","HALO","LU1880383440.USD","CTXR","LIPO","LU0289961442.SGD","BK4023","LU0949170772.SGD","FFWM","EYEN","CYH","NTAP","JTAI","LU0823426308.USD","BK4585","HON","BKE","ROST","LU0444971666.USD","LU2023251221.USD","LU0070302665.USD","TPR","WTW","INTU","HCA","LU0124676726.USD","FLEX","LU0072462343.USD","HUT","LU0821914370.USD","BK4139","CPRT","VKTX","THC","LU0348788117.USD","NEM","SLG","VTRS","EOG","LU0143863784.USD","LU0109392836.USD"],"gpt_icon":1},{"id":"2485265027","title":"BUZZ--美国股票走势-Tapestry、Eyenovia、Viking Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2485265027","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485265027?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:12","pubTimestamp":1732284740,"startTime":"0","endTime":"0","summary":"** Bloom Energy Corp   : BUZZ - AEP交易后，Jefferies上调Bloom Energy的PT值   ** Paypal Holdings Inc   : BUZZ - Piper Sandler 将 Paypal 的评级定为 \"中性\"。** Tapestry Inc   : BUZZ - 因 20 亿美元加速股票回购计划而上涨。** Viking Therapeutics Inc   ： BUZZ--上涨；B.Riley给予 \"买入 \"评级。** Coinbase Global Inc   ： ** Riot Platforms Inc   ： ** MARA Holdings Inc   ： ** Hut 8 Mining Corp   ： BUZZ - 比特币从历史高位回落，加密货币股下跌   ** Buckle Inc   : BUZZ - 季度销售下滑放缓后上涨   ** Lipella Pharmaceuticals Inc   : BUZZ - 在完成药物试验患者组的剂量后上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","NTAP","LU1981816686.USD","NEM","COIN","LU1043141123.HKD","EYEN","LU0353189680.USD","LU1868838027.USD","LU2089284900.SGD","VTRS","LU2265009873.SGD","SG9999002463.SGD","LU2462611646.USD","BK4519","LU0823434740.USD","HUT","LU1048588211.SGD","BK4137","LU0327786744.USD","BK4528","IE00B3M56506.USD","BK4596","ROST","LU0949170772.SGD","LIPO","LU0476273544.USD","BKE","BK4585","CPRT","LU2039709279.SGD","LU2089283258.USD","LENZ","RUN","TPR","BK4548","LU0345774631.USD","INTU","LU0561508036.HKD","LU0456854461.SGD","IE00BQXX3D17.EUR","VKTX","LU1430597077.USD","LU0072462343.USD"],"gpt_icon":1},{"id":"2485527292","title":"BUZZ--美国股票走势-金矿商 Ross Stores、NetApp","url":"https://stock-news.laohu8.com/highlight/detail?id=2485527292","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485527292?lang=zh_cn&edition=full","pubTime":"2024-11-22 20:46","pubTimestamp":1732279582,"startTime":"0","endTime":"0","summary":".N  ** 拼多多PDD.O： ** 百度BIDU.O： ** 阿里巴巴BBABA.N： ** JD.com Inc JD.O：BUZZ - 中国 ADRs 下跌，追随大陆同行的损失 nL4N3MT0PV  ** Intuit Inc INTU.O:BUZZ - 因第二季度营收和利润预期低于预期而下跌 nL4N3MT0OW   ** Newmont Corp NEM.N： ** 巴里克黄金公司 GOLD.N： ** Gold Fields Ltd GFI.N： ** Harmony Gold Mining Co Ltd HMY.N：BUZZ - 金矿商上涨，金银价格走高 nL4N3MT0QZ  ** Ross Stores Inc ROST.O:BUZZ - 因年度利润预期上调而飙升 nL4N3MT0R9  ** NetApp Inc NTAP.O:BUZZ - 因上调年度利润和收入预期而上涨 nL4N3MT0PM  ** Viatris Inc VTRS.O:BUZZ - 因被英国监管机构罚款 190 万美元而下跌 nL4N3MT0RV  ** Sunrun Inc RUN.O:BUZZ - 在 Piper Sandler 将其评级下调至 \"中性 \"后下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4S3MT0WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029875118.USD","GB00B4QBRK32.GBP","ROST","INTU","LU1323998911.USD","LU0823397103.USD","LU1769817179.HKD","SG9999002224.SGD","LU1803068979.SGD","BK4503","NEM","BE","BK1610","LU0300736062.USD","BK4596","LU0979878070.USD","LU0640476718.USD","LU0588546209.SGD","LU0588545904.SGD","BK4094","BK1591","VTRS","BK4587","LU0821914370.USD","LU0823434583.USD","SG9999014914.USD","LU1282649810.SGD","BK4551","SG9999001143.SGD","LU1121112475.USD","SG9999002232.USD","LU0823426480.USD","LU1956131251.USD","89618","IE00BKDWB100.SGD","NTAP","LU0957808578.USD","LU0456827905.SGD","RUN","LU0234570918.USD","BK4519","SG9999014906.USD","BK4514","V"],"gpt_icon":1},{"id":"2485625521","title":"BUZZ-被英国监管机构罚款 190 万美元后，Viatris 下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2485625521","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485625521?lang=zh_cn&edition=full","pubTime":"2024-11-22 19:24","pubTimestamp":1732274652,"startTime":"0","endTime":"0","summary":"11月22日 -  ** 制药商 Viatris Inc VTRS.O 股价盘前下跌 2.6%，报 12.91 美元 ** 英国竞争和市场管理局 对  VTRS 罚款 150 万英镑，原因是该公司在调查 Theramex 收购 Viatris 两个产品系列期间违反了具有法律约束力的限制规定。** CMA称，VTRS在未经监管机构同意的情况下对英国主要员工进行了未经批准的调整，且未报告违规情况。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4T3MT0SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","VTRS","BK4007","LU1839511570.USD","LU2087621335.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2485232937","title":"英国监管机构对 Viatris 违反 Theramex 调查规定罚款 190 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485232937","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485232937?lang=zh_cn&edition=full","pubTime":"2024-11-22 17:57","pubTimestamp":1732269471,"startTime":"0","endTime":"0","summary":"英国监管机构对 Viatris 违反 Theramex 调查规定罚款 190 万美元路透11月22日 - 英国竞争监督机构周五对美国公司ViatrisVTRS.O处以150万英镑的罚款，，原因是该公司在调查Theramex收购Viatris两个妇女保健产品系列的欧洲权利期间违反了一项命令。竞争与市场管理局 称，Viatris 违反了相关规定，因为它在更换关键员工之前没有征得其同意，也没有报告违规行为。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nL4T3MT0OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VTRS","BK4583","LU1839511570.USD","LU2087621335.USD","BK4585","BK4007"],"gpt_icon":0},{"id":"2484102005","title":"晖致2024财年第三财季实现净利润94.80百万美元，同比减少71.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484102005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484102005?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:01","pubTimestamp":1731772898,"startTime":"0","endTime":"0","summary":"11月17日，晖致公布财报，公告显示公司2024财年第三财季净利润为94.80百万美元，同比减少71.45%；其中营业收入为37.57亿美元，同比减少4.30%，每股基本收益为0.08美元。通过强强联手，晖致医药有限公司成为世界上最大的仿制药制造商之一，为超过 165 个国家提供服务。虽然涵盖 10 多个主要治疗领域，但晖致医药有限公司已将皮肤科、眼科和胃肠科确定为未来创新的三个关键重点领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000235abc78f6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000235abc78f6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTRS"],"gpt_icon":0},{"id":"2481136077","title":"Viatris 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481136077","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481136077?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:22","pubTimestamp":1731000131,"startTime":"0","endTime":"0","summary":"Viatris 公司报告截至 9 月 30 日的季度业绩 - 收益摘要Viatris Inc VTRS.OQ 公布的截至 9 月 30 日的季度调整后每股收益为 75 美分，低于去年同期的每股收益 79 美分。华尔街预期为每股收益 64 美分至 71 美分。营收同比下降 4.8%，至 37.5 亿美元；分析师预期为 37.1 亿美元。Viatris Inc 公布的本季度每股收益为 8 美分。公司报告的季度净收入为 9,480 万美元。本季度迄今为止，Viatris Inc 的股价保持稳定，今年迄今为止上涨了 7.2%。华尔街对 Viatris Inc 的 12 个月目标价中位数为 12.17 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4T3ME2H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4007","VTRS","BK4583","BK4585","LU1839511570.USD","BK4588"],"gpt_icon":0},{"id":"2481181093","title":"BUZZ-第三季度业绩超出预期，Viatris 将迎来两年来业绩最好的一天","url":"https://stock-news.laohu8.com/highlight/detail?id=2481181093","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481181093?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:05","pubTimestamp":1730991944,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    11月7日 - ** 制药商Viatris   股价上涨9%至12.65美元的三个月高点 ** 如果涨势得以保持，该股将迎来两年来最好的一天** 根据LSEG汇编的数据，伟哥生产商第三季度 (link)，营收37.4亿美元，超出华尔街预期的37.1亿美元。** 第三季度每股收益为75美分，高于预期的68美分。** 年初至今，股价上涨 16.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","BK4585","LU2087621335.USD","BK4583","BK4007","LU1839511570.USD","BK4588"],"gpt_icon":0},{"id":"2481095181","title":"BUZZ-第三季度业绩超出预期，Viatris 将迎来两年来业绩最好的一天","url":"https://stock-news.laohu8.com/highlight/detail?id=2481095181","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481095181?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:05","pubTimestamp":1730991944,"startTime":"0","endTime":"0","summary":"** 第三季度每股收益为75美分，高于预期的68美分。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4T3ME23I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VTRS","BK4583","LU1839511570.USD","LU2087621335.USD","BK4585","BK4007"],"gpt_icon":0},{"id":"1142747545","title":"异动解读 | 新药亮眼业绩超预期 Viatris股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142747545","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142747545?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:48","pubTimestamp":1730990923,"startTime":"0","endTime":"0","summary":"制药公司Viatris股价在11月7日盘中大涨5.08%,引发市场关注。公司新鲜出炉的第三季度财报成为推动股价上涨的主因。数据显示,Viatris第三季度营收达37.4亿美元,超过分析师预期的37.1亿美元。Viatris是2020年由默克和辉瑞旗下业务合并组建而成,在品牌药和仿制药两大领域都有版图。除了新产品销售亮眼,公司传统品牌药如伟哥、Xanax等也保持了稳健增长。本季度,其品牌药业务同比增长2%至23.6亿美元,仿制药业务增长4%至13.8亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 新药亮眼业绩超预期 Viatris股价大涨5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VTRS"],"gpt_icon":0},{"id":"2481890071","title":"晖致盘中异动 早盘快速上涨5.00%报12.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481890071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481890071?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:33","pubTimestamp":1730990034,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时33分，晖致股票出现异动，股价快速拉升5.00%。截至发稿，该股报12.19美元/股，成交量53.4534万股，换手率0.04%，振幅3.88%。晖致股票所在的制药行业中，整体涨幅为0.63%。通过强强联手，晖致医药有限公司成为世界上最大的仿制药制造商之一，为超过 165 个国家提供服务。虽然涵盖 10 多个主要治疗领域，但晖致医药有限公司已将皮肤科、眼科和胃肠科确定为未来创新的三个关键重点领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722335498e4131a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722335498e4131a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2087621335.USD","LU1839511570.USD","BK4585","VTRS","BK4583","BK4007","BK4588"],"gpt_icon":0},{"id":"2481790016","title":"新仿制药需求旺盛，安乃近制造商 Viatris 季度业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2481790016","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481790016?lang=zh_cn&edition=full","pubTime":"2024-11-07 21:52","pubTimestamp":1730987529,"startTime":"0","endTime":"0","summary":"Viatris 的产品组合包括勃起功能障碍药物伟哥、抗焦虑药物 Xanax、癫痫治疗药物 Lyrica 和关节炎治疗药物 Celebrex 等主要品牌药物。Viatris 于 6 月份完成了对妇女健康和活性药物成分   业务的剥离。根据 LSEG 编制的数据，这家制药商第三季度的收入为 37.4 亿美元，超过了 分析师平均预期的 37.1 亿美元。调整后的季度利润为每股 75 美分，也高于预期的 68 美分。不过，Viatris 将 2024 年的利润预期从之前的每股 2.58 美元至 2.73 美元下调至 2.56 美元至 2.71 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1894683348.USD","BK4551","LU0122379950.USD","LU0225284248.USD","IE00BLSP4452.SGD","VTRS","LU0225771236.USD","LU2087621335.USD","BK4592","BK4023","SG9999013999.USD","BK4585","BK4568","SG9999001176.USD","LU0289739699.SGD","LU1023059063.AUD","IE000M9KFDE8.USD","SG9999003800.SGD","BK4583","IE0002270589.USD","BK4535","LU0058720904.USD","LU0234572021.USD","SGXZ57979304.SGD","BK4581","BK4007","IE00BLSP4239.USD","API","SG9999002224.SGD","BK4533","LU0456855351.SGD","LU0985481810.HKD","LU1066051498.USD","LU1839511570.USD","SG9999002232.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4503","LU0170899867.USD","LU0868494617.USD","LU1066053197.SGD","BK4534","LU0306806265.USD","SG9999011175.SGD","SG9999001176.SGD","BK4550","LU0306807586.USD","LU0321505439.SGD"],"gpt_icon":1},{"id":"2481001999","title":"新仿制药需求旺盛，安乃近制造商 Viatris 季度业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2481001999","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481001999?lang=zh_cn&edition=full","pubTime":"2024-11-07 21:52","pubTimestamp":1730987529,"startTime":"0","endTime":"0","summary":"新仿制药需求旺盛，安乃近制造商 Viatris 季度业绩超出预期路透11月7日 - 制药商维特瑞VTRS.O周四公布的第三季度利润和营收超出华尔街预期，这主要得益于其哮喘和多动症等新仿制药的强劲需求，该公司股价盘前上涨了2.5%。Viatris 于 6 月份完成了对妇女健康和活性药物成分   业务的剥离。不过，Viatris 将 2024 年的利润预期从之前的每股 2.58 美元至 2.73 美元下调至 2.56 美元至 2.71 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4T3ME1N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","BK4588","LU0225771236.USD","BK4581","LU0058720904.USD","LU0823416689.USD","PFE","SG9999002232.USD","LU1894683348.USD","SG9999003800.SGD","LU0170899867.USD","BK4568","AZN.UK","IE00BLSP4239.USD","LU0957799991.USD","SG9999002224.SGD","LU0077335932.USD","LU0203347892.USD","BK4533","LU0310799852.SGD","LXRX","LU0784385840.USD","VTRS","LU0976567544.SGD","BK5011","LU1894683264.USD","LU0868494617.USD","BK4585","LU1839511570.USD","LU0997586432.USD","LU0114720955.EUR","LU0985481810.HKD","LU0792757196.USD","LU0011850046.USD","SG9999001176.USD","LU0882574055.USD","LU0949170426.SGD","03165","LU0047473722.EUR","LU0203345920.USD","LU0889565080.SGD","IE00B2B36J28.USD","LU0225284248.USD","LU0963555726.SGD","LU0553294199.USD","IE0002141913.USD","LU0456855351.SGD","BK4534","LU0661504455.SGD","LU0211327993.USD"],"gpt_icon":1},{"id":"2474826278","title":"BUZZ-Viatris 的焦虑症药物在后期试验中达到主要目标；股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2474826278","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474826278?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:42","pubTimestamp":1728488555,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透10月9日 - **制药商Viatris   股价上涨1%，报11.44美元 ** 该公司的药物Effexor (link) 在治疗日本成年患者广泛性焦虑症的后期研究中达到了主要和次要目标(GAD) ** 研究显示，在治疗焦虑症 8 周时，艾菲克索的疗效优于安慰剂** 艾菲克索的耐受性总体良好，与已知的非日本患者的安全状况一致** 该公司计划于 2025 年向日本监管机构提交艾菲克索的申请** 艾菲克索在 80 多个国家被批准用于治疗 GAD** 包括本交易日的走势在内，该股今年累计上涨 5.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","VTRS","BK4007","LU2087621335.USD","BK4583","BK4585","BK4588"],"gpt_icon":0},{"id":"2472579443","title":"吉利德与 6 家仿制药生产商签署协议，在低收入国家销售艾滋病药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2472579443","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472579443?lang=zh_cn&edition=full","pubTime":"2024-10-03 00:52","pubTimestamp":1727887935,"startTime":"0","endTime":"0","summary":"    路透10月2日 - 吉利德科学公司  周三表示，该公司已向六家仿制药生产商授予了免版税许可，允许它们在120个低收入和中低收入国家生产和销售更廉价的仿制版艾滋病预防药物。这些国家约占艾滋病病例的 70%。该制药商表示，它将在今年年底前开始申请全球监管机构批准该药物作为预防艾滋病的治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU1571399168.USD","IE00B19Z3B42.SGD","VTRS","BK4583","LU1066051498.USD","IE00B19Z3581.USD","BK4007","BK4585","LU1585245621.USD","BK4588","LU0320765992.SGD","BK4568","LU0109394709.USD","LU0234570918.USD","BK4550","LU2087621335.USD","BK4566","BK4578","GILD","BK4532","LU1839511570.USD","LU0058720904.USD","BK4139","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0889565916.HKD","LU1066053197.SGD","LU2468319806.SGD","IE0002270589.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2468621448","title":"晖致盘中异动 早盘急速下跌5.00%报11.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468621448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468621448?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:11","pubTimestamp":1726841500,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时11分，晖致股票出现异动，股价快速下跌5.00%。截至发稿，该股报11.31美元/股，成交量237.805万股，换手率0.20%，振幅3.78%。晖致股票所在的制药行业中，整体涨幅为1.26%。通过强强联手，晖致医药有限公司成为世界上最大的仿制药制造商之一，为超过 165 个国家提供服务。虽然涵盖 10 多个主要治疗领域，但晖致医药有限公司已将皮肤科、眼科和胃肠科确定为未来创新的三个关键重点领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092022114198e38448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092022114198e38448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTRS","BK4007","BK4583","LU1839511570.USD","BK4588","LU2087621335.USD","BK4585"],"gpt_icon":0},{"id":"2464832025","title":"美国允许增加武田多动症药物的产量以解决短缺问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2464832025","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464832025?lang=zh_cn&edition=full","pubTime":"2024-09-04 18:57","pubTimestamp":1725447431,"startTime":"0","endTime":"0","summary":"    路透9月4日 - 美国缉毒署 已将武田制药  的多动症药物Vyvanse及其仿制药的生产限额提高了约24%，以解决该药在美国持续短缺的问题。美国食品和药物管理局在2022年10月警告 ，以色列制药商Teva Pharmaceutical Industries的  Adderall因生产延误而出现短缺。这导致需求激增，武田的Vyvanse随之出现短缺。Vyvanse又名利眠宁，被美国缉毒署列为第二类管制药物，适用于被认为极有可能被滥用的药物，并规定了额外的处方保障措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","LU1839511570.USD","LU2087621335.USD","VTRS","ADHD","BK4588","BK4583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.viatris.com","stockEarnings":[{"period":"1week","weight":-0.0032},{"period":"1month","weight":-0.0658},{"period":"3month","weight":0.0908},{"period":"6month","weight":0.1975},{"period":"1year","weight":0.1728},{"period":"ytd","weight":0.1533}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viatris Inc.于2019年2月14日在特拉华州成立。该公司是一家全球性的医疗保健公司，该公司认为他们具有独特的定位，可以弥合仿制药和品牌之间的传统鸿沟，将两者的优点结合起来，以更全面地满足全球范围内的医疗保健需求。Viatris的使命是赋能世界各地的人们在生命的每个阶段都能过上更健康的生活，它大规模地提供准入服务，目前每年为全球约10亿患者提供高质量的药物，并触及生命的所有时刻，从出生到生命的尽头，从急性病到慢性病。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.048097},{"month":2,"riseRate":0.25,"avgChangeRate":-0.100502},{"month":3,"riseRate":0,"avgChangeRate":-0.065492},{"month":4,"riseRate":0,"avgChangeRate":-0.039911},{"month":5,"riseRate":0.5,"avgChangeRate":0.057634},{"month":6,"riseRate":0.5,"avgChangeRate":-0.028874},{"month":7,"riseRate":0.5,"avgChangeRate":0.024935},{"month":8,"riseRate":0.75,"avgChangeRate":0.011976},{"month":9,"riseRate":0,"avgChangeRate":-0.075843},{"month":10,"riseRate":0.25,"avgChangeRate":0.018996},{"month":11,"riseRate":0.75,"avgChangeRate":0.042713},{"month":12,"riseRate":0.8,"avgChangeRate":0.071245}],"exchange":"NASDAQ","name":"Viatris Inc.","nameEN":"Viatris Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viatris Inc.(VTRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viatris Inc.,VTRS,Viatris Inc.股票,Viatris Inc.股票老虎,Viatris Inc.股票老虎国际,Viatris Inc.行情,Viatris Inc.股票行情,Viatris Inc.股价,Viatris Inc.股市,Viatris Inc.股票价格,Viatris Inc.股票交易,Viatris Inc.股票购买,Viatris Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viatris Inc.(VTRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viatris Inc.(VTRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}